A Case for Participatory Disease Surveillance of the COVID-19 Pandemic in India
A Case for Participatory Disease Surveillance of the COVID-19 Pandemic in India
复制标题
DOI：
10.2196/18795
复制
发表时间：
2020-04-01
影响因子：
8.5
通讯作者：
Gangadharan, Navya
中科院分区：
文献类型：
--
作者：
Garg, Suneela;Bhatnagar, Nidhi;Gangadharan, Navya
冠状病毒病大流行需要部署新的监测策略，以遏制疾病在社区的进一步传播。针对目前的大流行病，各国已经采用了预防性疾病监测机制。印度资源稀缺，电信支持良好，卫生保健系统不太健全，因此有充分理由引入参与性疾病监测，以预防和控制这一流行病。印度刚刚启动了Aarogya Setu，这是印度第一个参与性疾病监测倡议。这将补充印度现有的综合疾病监测方案，发现缺失病例，加快数据汇总、分析和及时应对措施。这个新创建的平台为社区提供了正确的信息和指导，使其能够免受感染，并减少与负担过重的卫生保健系统的不必要接触。然而，需要谨慎处理数字隔离人群的参与问题，确保数据的可靠性，并考虑维护个人隐私等道德问题。
The coronavirus disease pandemic requires the deployment of novel surveillance strategies to curtail further spread of the disease in the community. Participatory disease surveillance mechanisms have already been adopted in countries for the current pandemic. India, with scarce resources, good telecom support, and a not-so-robust heath care system, makes a strong case for introducing participatory disease surveillance for the prevention and control of the pandemic. India has just launched Aarogya Setu, which is a first-of-its-kind participatory disease surveillance initiative in India. This will supplement the existing Integrated Disease Surveillance Programme in India by finding missing cases and having faster aggregation, analysis of data, and prompt response measures. This newly created platform empowers communities with the right information and guidance, enabling protection from infection and reducing unnecessary contact with the overburdened health care system. However, caution needs to be exercised to address participation from digitally isolated populations, ensure the reliability of data, and consider ethical concerns such as maintaining individual privacy.